Subgroup analysis and interpretation for phase 3 confirmatory trials: White paper of the EFSPI/PSI working group on subgroup analysis. (2019)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/pst.1919

PubMed Identifier: 30592133

Publication URI: http://europepmc.org/abstract/MED/30592133

Type: Journal Article/Review

Volume: 18

Parent Publication: Pharmaceutical statistics

Issue: 2

ISSN: 1539-1604